Impaired control of epstein-Barr virus infection in B-cell expansion with NF-κB and T-cell anergy disease

Swadhinya Arjunaraja, Pamela Angelus, Helen C. Su, Andrew L. Snow*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

27 Scopus citations

Abstract

B-cell expansion with NF-κB and T-cell anergy (BENTA) disease is a B-cell-specific lymphoproliferative disorder caused by germline gain-of-function mutations in CARD11. These mutations force the CARD11 scaffold into an open conformation capable of stimulating constitutive NF-κB activation in lymphocytes, without requiring antigen receptor engagement. Many BENTA patients also suffer from recurrent infections, with 7 out of 16 patients exhibiting chronic, low-grade Epstein-Barr virus (EBV) viremia. In this mini-review, we discuss EBV infection in the pathogenesis and clinical management of BENTA disease, and speculate on mechanisms that could explain inadequate control of viral infection in BENTA patients.

Original languageEnglish
Article number198
JournalFrontiers in Immunology
Volume9
Issue numberFEB
DOIs
StatePublished - 8 Feb 2018
Externally publishedYes

Keywords

  • B-cell expansion with NF-κB and T-cell anergy
  • CARD11
  • Epstein-Barr virus
  • NF-κB
  • Primary immune deficiency

Cite this